Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Clinical Advances in Hematology & Oncology : H&O
|
January 17, 2025
The use of zenocutuzumab for NRG1 fusion-positive tumors
Alison Schram
The New England Journal of Medicine
|
August 13, 2015
INTERACTIVE MEDICAL CASE. A Man with Bizarre Behavior
Chevon M Rariy, Alison Schram, Daniel T Ruan, et al.
JCO Precision Oncology
|
September 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract Cancer
Darren Cowzer, Madison Darmofal, Kenneth Seier, et al.
Nature Medicine
|
April 23, 2024
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses
Claire F Friedman, Beryl L Manning-Geist, Qin Zhou, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Clinical Advances in Hematology & Oncology : H&O
|
January 17, 2025
The use of zenocutuzumab for NRG1 fusion-positive tumors
Alison Schram
The New England Journal of Medicine
|
August 13, 2015
INTERACTIVE MEDICAL CASE. A Man with Bizarre Behavior
Chevon M Rariy, Alison Schram, Daniel T Ruan, et al.
JCO Precision Oncology
|
September 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract Cancer
Darren Cowzer, Madison Darmofal, Kenneth Seier, et al.
Nature Medicine
|
April 23, 2024
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses
Claire F Friedman, Beryl L Manning-Geist, Qin Zhou, et al.
Page
of 1